Our team, including Martin Holm-Petersen (CEO), Jen Markey (Chief Sales and Marketing Officer), Wilfred Gilich (Vice President, US Operations) and Petra Dinghaus (Associate Director, Business Services), were on-site at Booth 742 to represent Insife and demonstrate our industry-leading pharmacovigilance platform, HALOPV.
HALOPV is a game changing platform, with a unique subscription model, that will revolutionize your PV System with comprehensive and integrated modules for end-to-end Pharmacovigilance. Its new features will transform the way that companies can manage their PV processes and promises to create a unified ‘Integrated Universe’ that all pharma companies can enjoy, regardless of their size.
On October 29, 2024, Martin Holm-Petersen delivered an insightful session titled “Future-proofing Pharmacovigilance: Governance, Data Collection, and Analyses for Global Success” in Room 051. Later that day, he joined a roundtable discussion on advancing pharmacovigilance governance and strategies, sharing his expertise and vision for the future of the industry.
The congress highlighted Insife’s mission to empower life sciences, with HALOPV driving innovation for global patient safety. We extend our heartfelt thanks to everyone who visited Booth 742 and engaged with our team.
The future of pharmacovigilance is here, and Insife is proud to lead the charge.
